[DPHARMA] YoY Quarter Result on 31-Dec-2015 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
23-Feb-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
31-Dec-2015 [#4]
Profit Trend
QoQ- 77.84%
YoY- 37.92%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 115,634 112,253 74,033 89,401 51,024 45,734 35,378 21.81%
PBT 17,658 12,825 6,299 17,529 13,921 9,160 9,000 11.88%
Tax -3,289 -1,057 2,532 0 0 153 -3,002 1.53%
NP 14,369 11,768 8,831 17,529 13,921 9,313 5,998 15.66%
-
NP to SH 14,369 11,870 8,428 15,335 11,119 9,313 5,998 15.66%
-
Tax Rate 18.63% 8.24% -40.20% 0.00% 0.00% -1.67% 33.36% -
Total Cost 101,265 100,485 65,202 71,872 37,103 36,421 29,380 22.89%
-
Net Worth 483,173 479,809 454,703 270,177 192,951 181,818 169,359 19.08%
Dividend
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Div 26,475 16,737 11,158 9,172 20,128 18,737 14,576 10.45%
Div Payout % 184.25% 141.01% 132.40% 59.82% 181.02% 201.19% 243.02% -
Equity
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Net Worth 483,173 479,809 454,703 270,177 192,951 181,818 169,359 19.08%
NOSH 661,881 278,959 278,959 278,959 138,813 138,792 138,819 29.71%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin 12.43% 10.48% 11.93% 19.61% 27.28% 20.36% 16.95% -
ROE 2.97% 2.47% 1.85% 5.68% 5.76% 5.12% 3.54% -
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
RPS 17.47 40.24 26.54 53.61 36.76 32.95 25.48 -6.09%
EPS 2.17 4.22 3.41 9.19 8.01 6.71 4.32 -10.83%
DPS 4.00 6.00 4.00 5.50 14.50 13.50 10.50 -14.85%
NAPS 0.73 1.72 1.63 1.62 1.39 1.31 1.22 -8.19%
Adjusted Per Share Value based on latest NOSH - 278,959
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
RPS 12.02 11.67 7.70 9.29 5.30 4.75 3.68 21.79%
EPS 1.49 1.23 0.88 1.59 1.16 0.97 0.62 15.72%
DPS 2.75 1.74 1.16 0.95 2.09 1.95 1.52 10.38%
NAPS 0.5023 0.4988 0.4727 0.2809 0.2006 0.189 0.1761 19.07%
Price Multiplier on Financial Quarter End Date
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Date 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 -
Price 0.95 2.53 1.98 2.62 2.50 2.58 2.13 -
P/RPS 5.44 6.29 7.46 4.89 6.80 7.83 8.36 -6.90%
P/EPS 43.76 59.46 65.54 28.49 31.21 38.45 49.30 -1.96%
EY 2.29 1.68 1.53 3.51 3.20 2.60 2.03 2.02%
DY 4.21 2.37 2.02 2.10 5.80 5.23 4.93 -2.59%
P/NAPS 1.30 1.47 1.21 1.62 1.80 1.97 1.75 -4.83%
Price Multiplier on Announcement Date
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Date 18/02/19 28/02/18 24/02/17 23/02/16 24/02/15 26/02/14 25/02/13 -
Price 1.03 2.97 2.23 2.61 2.92 2.60 2.17 -
P/RPS 5.90 7.38 8.40 4.87 7.94 7.89 8.51 -5.91%
P/EPS 47.45 69.80 73.81 28.39 36.45 38.75 50.22 -0.94%
EY 2.11 1.43 1.35 3.52 2.74 2.58 1.99 0.98%
DY 3.88 2.02 1.79 2.11 4.97 5.19 4.84 -3.61%
P/NAPS 1.41 1.73 1.37 1.61 2.10 1.98 1.78 -3.80%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment